Considerations for the development of health-based surface dust cleanup criteria for beryllium
Authors:
- 12 February 2013
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 43 (3) , 220-243
Abstract
The exposure–response patterns with beryllium sensitization (BeS), chronic beryllium disease (CBD) and lung cancer are influenced by a number of biological and physicochemical factors. Recent studies have suggested dermal exposure as a pathway for BeS. In light of the current non-health-based DOE Beryllium Rule surface criteria, the feasibility of deriving a human health-based surface dust cleanup criteria (SDCC) for beryllium was assessed based on toxicology and health risk factors via all potential routes of exposure. Beryllium-specific and general exposure factors were evaluated, including (1) beryllium physicochemical characteristics, bioavailability and influence on disease prevalence, and (2) chemical dissipation, resuspension and transfer. SDCC for non-cancer (SDCCNC) and cancer (SDCCCA) endpoints were derived from a combination of modern methods applied for occupational, residential and building reentry surface dust criteria. The most conservative SDCCNC estimates were derived for dermal exposure (5–379 μg/100 cm2 for 0.1–1% damaged skin and 17–3337 μg/100 cm2 for intact skin), whereas the SDCCCA for inhalation exposure ranged from 51 to 485 μg/100 cm2. Considering this analysis, the lowest DOE surface criterion of 0.2 μg/100 cm2 is conservative for minimizing exposure and potential risks associated with beryllium-contaminated surfaces released for non-beryllium industrial or public sector use. Although methodological challenges exist with sampling and analysis procedures, data variability and interpretation of surface dust information in relation to anthropogenic and natural background concentrations, this evaluation should provide useful guidance with regard to cleanup of manufacturing equipment or remediation of property for transfer to the general public or non-beryllium industrial facilities.Keywords
This publication has 94 references indexed in Scilit:
- Beryllium Metal II. A Review of the Available Toxicity DataAnnals of Occupational Hygiene, 2010
- Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium diseaseAmerican Journal of Industrial Medicine, 2009
- Beryllium and lung cancer: A weight of evidence evaluation of the toxicological and epidemiological literatureCritical Reviews in Toxicology, 2009
- Immunotoxicology of beryllium lung diseaseEnvironmental Health and Preventive Medicine, 2007
- Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workersOccupational and Environmental Medicine, 2006
- Exposure Pathway Assessment at a Copper–Beryllium Alloy FacilityAnnals of Occupational Hygiene, 2006
- Diagnostic relevance of the lymphocyte transformation test for sensitization to beryllium and other metals (IUPAC Technical Report)Pure and Applied Chemistry, 2004
- Chronic Beryllium Disease—From the Workplace to Cellular Immunology, Molecular Immunogenetics, and BackClinical Immunology and Immunopathology, 1994
- Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T CellsNew England Journal of Medicine, 1989
- Beryllium: An etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed workersEnvironmental Research, 1980